Tiagabine hydrochloride

Drug ingredient

CAS 145821-59-6

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 145821-59-6
1 HCl
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

7 FDA-registered drug labelers
Cephalon, LLC
MAHI DRUGS PRIVATE LIMITED
MSN Life Sciences Private Limited
Novadoz Pharmaceuticals LLC
Siegfried Malta Limited
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceuticals USA, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Tiagabine Hydrochloride
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Tiagabine Hydrochloride Tablet

    Shortage listed since April 15, 2026

See all current drug shortages

Chemical Identity

CAS145821-59-6
PubChem CID91274
DTXSIDDTXSID2044218
FormulaC20H26ClNO2S2
Mol. Weight412 g/mol
SMILESCC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C.Cl

Data Sources

Brief citations

Tiagabine hydrochloride (CAS 145821-59-6) https://chemicalindependence.com/chemical/145821-59-6/ PubChem: 91274. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/91274 FDA National Drug Code directory: CAS 145821-59-6. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 145821-59-6. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/